Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook

Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook

Abstract Immunotherapy (IO) has revolutionized the therapy landscape of non-small cell lung cancer (NSCLC), significantly prolonging the overall survival (OS) of advanced stage patients. Over the recent years IO therapy has been broadly integrated into the first-line setting of non-oncogene driven N...

Full description

Bibliographic Details
Main Authors: Lena Horvath, Bernard Thienpont, Liyun Zhao, Dominik Wolf, Andreas Pircher
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Molecular Cancer
Subjects:
NSCLC
Immunotherapy resistance
Tumor microenvironment heterogeneity
Targeted therapy
Online Access:http://link.springer.com/article/10.1186/s12943-020-01260-z

Internet

http://link.springer.com/article/10.1186/s12943-020-01260-z

Similar Items